[go: up one dir, main page]

EA000877B1 - Способ получения ингибиторов фосфодиэстеразы iv - Google Patents

Способ получения ингибиторов фосфодиэстеразы iv Download PDF

Info

Publication number
EA000877B1
EA000877B1 EA199800931A EA199800931A EA000877B1 EA 000877 B1 EA000877 B1 EA 000877B1 EA 199800931 A EA199800931 A EA 199800931A EA 199800931 A EA199800931 A EA 199800931A EA 000877 B1 EA000877 B1 EA 000877B1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkenyl
alkyl
phenyl
compound
znmgbr
Prior art date
Application number
EA199800931A
Other languages
English (en)
Russian (ru)
Other versions
EA199800931A1 (ru
Inventor
Иоаннис Хоупис
Одри Молина
Ральф П. Волант
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612083.7A external-priority patent/GB9612083D0/en
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA199800931A1 publication Critical patent/EA199800931A1/ru
Publication of EA000877B1 publication Critical patent/EA000877B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • C07D213/34Sulfur atoms to which a second hetero atom is attached
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EA199800931A 1996-04-17 1997-04-14 Способ получения ингибиторов фосфодиэстеразы iv EA000877B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1568796P 1996-04-17 1996-04-17
GBGB9612083.7A GB9612083D0 (en) 1996-06-10 1996-06-10 Method of preparing phosphodiesterase IV inhibitors
PCT/US1997/006131 WO1997038976A1 (en) 1996-04-17 1997-04-14 Method of preparing phosphodiesterase iv inhibitors

Publications (2)

Publication Number Publication Date
EA199800931A1 EA199800931A1 (ru) 1999-04-29
EA000877B1 true EA000877B1 (ru) 2000-06-26

Family

ID=26309476

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800931A EA000877B1 (ru) 1996-04-17 1997-04-14 Способ получения ингибиторов фосфодиэстеразы iv

Country Status (10)

Country Link
EP (1) EP0898564A1 (pt)
CN (1) CN1216532A (pt)
AR (1) AR006550A1 (pt)
AU (1) AU2459297A (pt)
BR (1) BR9708684A (pt)
CZ (1) CZ333298A3 (pt)
EA (1) EA000877B1 (pt)
SK (1) SK143198A3 (pt)
TW (1) TW426669B (pt)
WO (1) WO1997038976A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW508353B (en) * 1996-09-17 2002-11-01 Merck & Co Inc Method of preparing phosphodiesterase IV inhibitors
WO1998012178A1 (en) * 1996-09-17 1998-03-26 Merck & Co., Inc. Method of preparing phosphodiesterase iv inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (pt) * 1992-12-23 1995-11-21 Celltech Ltd
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process

Also Published As

Publication number Publication date
WO1997038976A1 (en) 1997-10-23
SK143198A3 (en) 1999-06-11
TW426669B (en) 2001-03-21
AU2459297A (en) 1997-11-07
CZ333298A3 (cs) 1999-03-17
CN1216532A (zh) 1999-05-12
EA199800931A1 (ru) 1999-04-29
BR9708684A (pt) 1999-08-03
EP0898564A1 (en) 1999-03-03
AR006550A1 (es) 1999-09-08

Similar Documents

Publication Publication Date Title
US4613610A (en) Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
EP0244364A2 (en) Preparation of olefinic compounds
EP3753926B1 (en) Spiro compound as indoleamine-2,3-dioxygenase inhibitor
EP0265640A2 (en) Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals
US5541329A (en) Intermediates prepared in an asymmetric total synthesis of camptothecin analogs
US4822799A (en) Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals
EP1189890B1 (fr) Dihydrobenzodiazepines et leur utilisation dans le traitement de dyslipidemies
US4939159A (en) Azaindole derivatives useful as cholesterol biosynthesis inhibitors
EP0111997A2 (en) Vinyl carboxylic acid derivatives, their production and use
CZ305964B6 (cs) Způsob syntézy prostaglandinů
EA000877B1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
US5346912A (en) 2-cyano-3-hydroxy-(n-pyridyl)-propenamide compounds
WO2009024323A2 (en) Process for preparing pyrimidine derivatives
CA3132365A1 (en) Novel synthetic options towards the manufacture of (6r,10s)-10- {4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)- pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7 8,9,10-hexahydro-11,15-(metheno)pyrazolo [4,3-b][1,7]diazacyclotetradecin-5(6h)-one
US5554764A (en) Preparation of pyrrol and oxazole compounds: formation of C-acyl-α-amino acid esters therefrom
US5728838A (en) Method of preparing phosphodiesterase IV inhibitors
EP2084125B1 (fr) Derives d'aminobenzocycloheptene, leurs procedes de preparation et leur utilisation en therapeutique
US4755612A (en) Intermediate compounds resulting from method for forming a dihydrogen-phosphate inositol
EP0300249A1 (de) 7-[1H-Pyrrol-3-yl]-substituierte 3,5-Dihydroxy-heptansäuren, ihre entsprechenden delta-Lactone und Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und Zwischenprodukte
TWI870909B (zh) 用於製備奈瑪特韋(nirmatrelvir)之方法及中間體
RU2260001C2 (ru) Способ получения 7-хинолинил-3,5-дигидроксигепт-6-еноата
WO1998031671A1 (fr) Derives de pyridone, leur preparation et leur utilisation comme intermediaires de synthese
KR20000026291A (ko) 캐테콜 히드라진 유도체, 이의 제조 방법 및 이를 함유한 약제학적 조성물
US4973704A (en) Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof
Cossy et al. Radical Cyclizations–Synthesis of γ‐Lycorane

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU